Establishing congenital (lifelong) urology as a distinct medical subspecialty: Rationale, evidence, and a framework for Saudi Arabia
Khalid Fouda Neel, Mahmoud S. Tarbay, Mohamed Adwan, Abdullah Khalid Neel, Basim Alsaywid, Serdar TekgulAbstract
Congenital urological conditions, including posterior urethral valves (PUVs), bladder exstrophy, neurogenic bladder, differences of sex development (DSD), and complex hypospadias, impose a lifelong disease burden extending far beyond pediatric care. Advances in neonatal medicine and pediatric surgery have created a rapidly growing adult population with complex congenital urological sequelae who currently fall between the specialist domains of pediatric and adult urology. This care gap results in preventable morbidity, renal deterioration, psychosocial harm, and substantial economic cost. This narrative review (1) traces the historical emergence of congenital (lifelong) urology as a discipline; (2) synthesizes evidence on long-term outcomes across major congenital urological conditions; (3) examines the economic and social rationale for structured lifelong care; (4) analyzes the particular need in Saudi Arabia; and (5) proposes a practical framework for bridging the current care gap. A narrative review of the MEDLINE/PubMed, Embase, and Cochrane Library databases was conducted to identify English-language publications from January 1980 through March 2025. Search terms included combinations of: congenital urology, lifelong urology, transition of care, PUVs, bladder exstrophy, spina bifida (SB), neurogenic bladder, DSD, and Saudi Arabia. Eligible publications were selected based on their clinical relevance, recency, and methodological quality, with priority given to systematic reviews, large cohort studies, and landmark publications. Expert opinion was used only to supplement areas where primary evidence was limited. Long-term follow-up studies consistently demonstrate that congenital urological conditions like PUV, bladder exstrophy, SB, and DSD are associated with substantial adult morbidity across multiple clinical domains. Published series indicate that up to one-third of patients with PUV develop end-stage renal disease by early adulthood reported rates of significant urological re-intervention in bladder exstrophy reach up to 50% in some cohorts, patients with SB experience profound deficits in sexual function, employment, and independent living, and individuals with DSD face significant psychological distress, sexual dysfunction, and fertility challenges. Across these heterogeneous conditions, the literature consistently identifies inadequate transition from pediatric to adult care as a major contributor to loss to follow-up and preventable long-term complications. Foundational work by Woodhouse and the landmark 2019 European Urology consensus statement by Wood